Nektar Therapeutics logo

Nektar Therapeutics

FRA:ITH (USA)   Ordinary Shares
€ 1.14 (-8.19%) May 31
At Loss
P/B:
1.84
Market Cap:
€ 215.77M ($ 234.25M)
Enterprise V:
€ 54.05M ($ 58.68M)
Volume:
-
Avg Vol (2M):
2.14K
Also Trade In:

Nektar Therapeutics (FRA:ITH) Stock News, Headlines & Updates

Nektar Therapeutics Stock News from GuruFocus

Total 52
  • 1
  • 2
May 30, 2024
May 10, 2024
May 02, 2024
Mar 22, 2024
Mar 05, 2024
Q4 2023 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 11:00pm
Q3 2023 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:03pm
Q2 2023 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:03pm
Q1 2023 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:03pm
Q3 2022 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q2 2022 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q4 2021 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Nektar Therapeutics ESMO-IO Congress Call Transcript
GuruFocus Research • 10:02pm
Q3 2021 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q2 2021 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q1 2021 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q4 2020 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q3 2020 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q2 2020 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Q1 2020 Nektar Therapeutics Earnings Call Transcript
GuruFocus Research • 10:02pm
Total 52
  • 1
  • 2
Show
Entries

Headlines

Total 0
  • 1
No recent news